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The pathogenesis of diabetic retinopathy is still 
unknown. Altered basement membrane, blood flow 
properties, oxygen transport, hormone production, cell 
metabolism, and disturbed hemostats have been 
implicated as possible mechanisms [ 1] . Some of these 
presumed mech~~sms ay be mediated via protein 
kinase and phospho~lat~on f cellular proteins. 
We have previously observed that platelet aggrega- 
tion was increased in patients with diabetic retin- 
opathy f2] ‘ Platelet aggregation may be due to altered 
phosphory~tion of the platelet membrane proteins 
mediated by a change of the activity or types of intra- 
celhrlar protein kinases. Our results, presented in this 
paper, show that platelets of patients with diabetic 
ret~opa~y exhibited increased activity levels of 
LAMP-~dependent protein kinase, Concomitantly, 
endogenous platelet protein phospho~lation was 
higher in diabetic patients than in control patients. 
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2. Mhxials and methods 
All biochemical reagents were obtained from Sigma 
Chemical Company. [y”PJATP, ammonium salt 
(2-10 Ci/mmol) was from New England Nuclear. 
Blood was obtained from patients with pro~ferative 
diabetic retinopathy in siliconized tubes containing 
3.8% sodium citrate. Platelets were collected and lysed 
according to Zeller et al. [3] . A platelet count was 
obtained using the Codter counter. Protein kinase 
activity was assayed in a total reaction volume of 
0.2 ml for 10 min at 30°C as previously described by 
us [4]. Each assay was performed in triplicate. Heat- 
stable protein kinase inhibitor protein was prepared 
and partiahy purified from rabbit skeletal muscle [S] . 
Platelet lysates were subjected to chromatography on 
Whatman DEAE-ce~ulose (DE-52) pre~qu~ibrated 
in 20 mM Trisf.5 mM dit~othreitol (pH 7.4). Elution 
was carried out with a linear KCl gradient (0.0-0.5 M 
KC1 in 20 mM T&/S mM dithiothreitol (pH 7.4). 
Polyacrylamide gel electrophoresis for identi~cation 
of endogenou~y phosphorylated proteins in platelet 
lysates was performed according to Ehrlich et al. 163. 
Analysis of the data was based on methods of multi- 
variate analysis of variance (and covariance) using least 
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squares estimation techniques [7]. However, the 
significance levels reported are based on the more 
familiar two sample univariate Student’s t-statistic. 
Significance values of P < 0.05 were considered to be 
non-significant, 
3. Results 
3.1. Effect of age on protein kinase activity 
Figures 1 and 3 show that total protein kinase and 
CAMP-independent protein kinase activities tended to 
decrease with age in both normal and diabetic patients. 
However, the negative correlation was not statistically 
significant for either group. Cyclic AMP-dependent 
protein kinase activity increased slightly with age in 
both normal and diabetic patients (fig.2). The positive 
correlation for patients in either group was marginally 
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Fig.1. Total protein kinase activity in platelet lysates of 
normal and diabetic males (panel A) and females (panel B) 
as a function of age. Total protein kmase activity was mea- 
sured as described under section 2 in the presence of 10e6 M 
cyclic AMP with protamine as substrate. l, normal; o, diabetic 
patients. 
0 
* 4- 0 
0 
t 
T 
G 3- X 0 . 0 
b 2- 0 0 0 08 . 
T 0 . .* 00 
-0 . -0 0 
; ’ 
OS O 
. 
. 8; 
g0 
El 
1 1 1 
5 B 
K 4 t 
z 
% 3- 
00 
0 
0 
00 B 0. 
. 
h 2- 8. 0 . 
. . . 
I- 00. 
IO 20 30 40 50 60 70 80 
Age (yews) 
Fig.2. Cyclic AMP-dependent protein kinase activity in 
platelet lysates of normal and diabetic males (panel A) and 
females (panel B) as a function of age. Protein kinase activity 
was measured as described under section 2 in the presence of 
10m6 M cyclic AMP, without and with saturating concentra- 
tions of heat-stable protein kinase inhibitor. The cyclic AMP- 
dependent protein kinase activity was derived by subtracting 
the protein kinase activity measured in the presence of the 
inhibitor (values of fig.3) from the total protein kinase 
activity measured in the absence of the inhibitor but in the 
presence of cyclic AMP (values of fig.1). l , normal; o, diabetic 
patients. 
significant (P > 0.08) and was due primarily to the 
age contribution by the diabetic males. 
3.2. Protein kinase activity in normal and diabetic 
patients 
Total protein kinase activity was significantly 
higher (P < 0.029) in diabetic than normal patients 
(fig.1 and table 1). Cyclic AMP-dependent protein 
kinase activity did not differ significantly in diabetic 
and normal patients, but cyclic AMP-independent 
protein kinase activity was significantly (P < 0.009) 
higher in diabetic than in normal patients (fig.3 and 
table 1). Both diabetic males and females had higher 
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Table 1 
Comparison of protein kinase activity in normal and diabetic patients 
Sex Patients Number of Protein kinase activity 
patients (pmol Pi incorporated/min/lO’ platelets) 
CAMP-dependent CAMP-independent Total 
Male Normal 12 684 * 6.5 1581 + 143 2265 f 165 
Diabetic 22 760 + 88 2066 ?: 235 2793 f 292 
Female Normal 9 764 f 112 1612 f 162 2376 f 164 
Diabetic 13 712 * 121 2434 f 178 3146 f 213 
Significance level P P < 0.819 P< 0.009 P< 0.029 
Total, cyclic AMP-dependent, and cyclic AMP-independent protein kinase activities were mea- 
sured in individual platelet samples as described in legends of figs l-3. In this table the protein 
kinase levels illustrated in figs l-3 were averaged as listed in this table. The significance level is 
given for the two-tailed f-test statistic (54 degrees of freedom) for comparing means of normals 
(males and females) with diabetics (males and females). Each value is the mean f S.D. 
cyclic AMP-independent protein kinase activity than 
normal males and females but only the difference in 
the activity of the females was statistically significant 
(P < 0.005). 
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Fig.3. Cyclic AMP-independent protein kinase activity in 
platelet lysates of normal and diabetic males (panel A) and 
females (panel B) as a function of age. Protein kinase activity 
was measured as described under section 2 in the presence 
of lob6 M cyclic AMP and saturating concentrations of heat- 
stable inhibitor with protamine as substrate. l, normal; 
o, diabetic patients. 
3.3. Multiplicity of cyclic AMP-dependent protein 
kinase 
Since no quantitative differences of cyclic AMP- 
dependent protein kinase levels were identified in 
normal and diabetic patients, platelet soluble prep- 
arations were subjected to DEAE-cellulose chromatog- 
raphy to identify qualitative changes in type I versus 
type II cyclic AMP-dependent protein kinase iso- 
zyme patterns. DEAE-cellulose chromatography of 
platelet homogenates revealed the presence of the 
two cyclic AMP-dependent protein kinase isozymes 
eluting at 0.18 and at 0.25 M NaCl (data not shown). 
The chromatographic profiles of protein kinase 
activity did, however, not differ qualitatively or 
quantitatively in preparation from normal or diabetic 
patients. 
3.4. Effect of cyclic AMP on endogenous protein 
phosphorylation 
To study the effect of cyclic AMP on the phos- 
phorylation of endogenous platelet proteins by their 
endogenous protein kinases, platelets were incubated 
in the presence of [y-32P]ATP without and with 
1 OT6 M cyclic AMP. After phosphorylation the 
protein preparations were subjected to polyacrylamide 
slab gel electrophoresis [6]. After autoradiography of 
the slab gels it was found that cyclic AMP had no 
significant stimulatory effect on protein phosphoryl- 
ation in either normal or diabetic patients. However, 
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under identical phosphorylation conditions we con- 
sistently found higher levels of 32P incorporation 
into platelet proteins from diabetic patients than 
from normal patients (data not shown). These findings 
were expected in view of the identified higher activity 
of cyclic AMP-independent protein kinase in diabetic 
patients. Electrophoresis revealed no qualitative 
changes of composition of platelet proteins in normal 
and diabetic patients. 
4. Discussion 
Our results indicate that platelet protein kinase 
levels were significantly elevated in patients with pro- 
liferative diabetic retinopathy. The elevated activity 
was mainly contributed by the CAMP-independent 
protein kinase. The increase of cyclic AMP-independent 
protein kinase activity was reflected by an increased 
incorporation of 32P into platelet proteins of diabetic 
patients. 
There have been several reports uggesting that 
growth hormone may be implicated in the etiology 
of diabetic retinopathy [8-l 11. However, 
Christensen [ 121 has also described the beneficial 
effects of hypophysectomy and hypothyroidism on 
capillary fragility in diabetics. Steroid and thyroid 
hormones are believed to casue protein phosphoryla- 
tion primarily through stimulation of CAMP-indepen- 
dent protein kinases [131. In this study we have 
reported an increase in CAMP-independent protein 
kinase levels in diabetics. We believe that a correlation 
between CAMP-independent protein kinase, thyroid 
and steroid hormones may exist in diabetics with pro- 
liferative retinopathy. This correlation may be involved 
in the observed regression of diabetic proliferative 
retinopathy after hypophysectomy [9,10,12] . 
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